Victory Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-28,603
| Closed | -$3.9M | – | 2612 |
|
|
2020
Q3 | $3.9M | Sell |
28,603
-1,431
| -5% | -$152K | 0.01% | 1248 |
|
|
2020
Q2 | $2.9M | Sell |
30,034
-53,685
| -64% | -$4.48M | ﹤0.01% | 1315 |
|
|
2020
Q1 | $3.92M | Sell |
83,719
-4,203
| -5% | -$269K | 0.01% | 1151 |
|
|
2019
Q4 | $6.41M | Sell |
87,922
-8,039
| -8% | -$488K | 0.01% | 1129 |
|
|
2019
Q3 | $5M | Buy |
95,961
+65,656
| +217% | +$3.49M | 0.01% | 1166 |
|
|
2019
Q2 | $1.52M | Sell |
30,305
-44,150
| -59% | -$2.15M | ﹤0.01% | 1209 |
|
|
2019
Q1 | $3.87M | Buy |
74,455
+17,730
| +31% | +$817K | 0.01% | 913 |
|
|
2018
Q4 | $2.77M | Buy |
56,725
+5,590
| +11% | +$308K | 0.01% | 960 |
|
|
2018
Q3 | $3.33M | Sell |
51,135
-14,320
| -22% | -$842K | 0.01% | 987 |
|
|
2018
Q2 | $3.25M | Sell |
65,455
-10,080
| -13% | -$488K | 0.01% | 960 |
|
|
2018
Q1 | $3.69M | Buy |
75,535
+27,820
| +58% | +$1.45M | 0.01% | 890 |
|
|
2017
Q4 | $2.01M | Buy |
47,715
+8,700
| +22% | +$335K | ﹤0.01% | 1032 |
|
|
2017
Q3 | $1.67M | Sell |
39,015
-900
| -2% | -$28.7K | ﹤0.01% | 1054 |
|
|
2017
Q2 | $523K | Sell |
39,915
-620
| -2% | -$8.17K | ﹤0.01% | 1304 |
|
|
2017
Q1 | $533K | Buy |
40,535
+13,355
| +49% | +$171K | ﹤0.01% | 1299 |
|
|
2016
Q4 | $352K | Hold |
27,180
| – | – | ﹤0.01% | 1323 |
|
|
2016
Q3 | $444K | Buy |
+27,180
| New | +$491K | ﹤0.01% | 1278 |
|
Victory Capital Management's MYOK Position: Q4 2020 in Review
Victory Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 28,603 shares — an estimated $3.9M sold.
Victory Capital Management first reported a position in MYOK in Q3 2016 and held it in 17 quarters. The position peaked at $6.41M in Q4 2019. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Victory Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Victory Capital Management sold 28,603 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $3.9M.
- Victory Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q3 2016 and held it in 17 quarters.
- Victory Capital Management's MyoKardia, Inc. Common Stock position peaked at $6.41M in Q4 2019.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Victory Capital Management's 13F filing for Q4 2020, filed 1 Feb 2021.